2101625-18-5: Tetraxetan Related Compound A

Status: In-stock

Tetraxetan Related Compound A (CAS No: 2101625-18-5) Or 2,2?,2?-[10-(2-Ethoxy-2-oxoethyl)-1,4,7,10-tetraazacyclododecane-1,4,7-triyl]triacetic acid, Tetraxetan is used as a complexing agent, Its complexes have medical applications as contrast agents and cancer treatments.

Additional information on CAS 2101625-18-5

Catalogue No. VE008438
CAS No. 2101625-18-5
Molecular Formula C18H32N4O8
Molecular Weight 432.47 g/mol
Parent drug Tetraxetan
IUPAC Name 2, 2′, 2″-[10-(2-Ethoxy-2-oxoethyl)-1, 4, 7, 10-tetraazacyclododecane-1, 4, 7-triyl]triacetic acid
Synonyms N/A
References Sci-Hub, Fractionated radioimmunotherapy with 90Y-clivatuzumab tetraxetan and low-dose gemcitabine is active in advanced pancreatic cancer : A phase 1 trial, 10.1002/cncr.27592. (2012). Retrieved December 27, 2021, from Sci-hub.ee website: https://sci-hub.ee/10.1002/cncr.27592
Status In-stock

Request a quote

We Respond Within a Few Hours - Whether You're a New or Existing Client

Payment Made Simple: All major Credit/Debit cards accepted

Streamlined 3-Step Process from Quotes to Orders:

Product name:

2101625-18-5: Tetraxetan Related Compound A

"*" indicates required fields

Products quotation
This field is for validation purposes and should be left unchanged.